Registration Opens for SPIE Photonics West 2022
Registration has opened for SPIE Photonics West 2022, which will take place 22-27 January at the Moscone Center in San Francisco. The largest annual international conference in optics and photonics will bring together researchers, innovators, engineers, and business leaders from across the globe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211102005147/en/
Exhibition entrance at SPIE Photonics West 2020. (Photo: Business Wire)
SPIE, the international society for optics and photonics, welcomes the in-person return of the technical community to the most innovative, impactful, and informative week in photonics. Following local San Francisco requirements and national CDC recommendations for attendees’ health and safety, proof of COVID-19 vaccinations will be required for all participants.
Each year, Photonics West showcases the latest in applications, technologies, and discoveries in optics and photonics, with three major conferences: BiOS, highlighting new research in biophotonics, biomedical optics, and applications of medical imaging; LASE, with its focus on the laser industry and applications; and OPTO, covering optoelectronics, photonic materials, and optical devices. In addition, Quantum West will feature presentations from industry leaders working to move quantum technologies from benchtops to business. This year’s Photonics West program includes more than 4,000 technical presentations.
Featuring hundreds of product launches, live demonstrations, and technologies on display, the BiOS Expo and Photonics West Exhibition are free and open to the public. The BiOS Expo — featuring the latest technology in biomedical optics and healthcare applications — is open 22-23 January; the Photonics West Exhibition, 25-27 January, showcases the latest in optics and photonics innovations.
From the SPIE BiOS Hot Topics and conference plenary sessions to the Prism Awards, the SPIE Startup Challenge, and the week-long industry program, the symposium will showcase the latest technologies and industry developments across the optics and photonics spectrum. Confirmed plenary speakers include Stanford University’s Hongjie Dai; Nagoya University’s Hiroshi Amano; Nokia Bell Labs’ Andrea Blanco-Redondo; Stanford University’s Jelena Vučković; Lawrence Livermore National Lab’s Tammy Ma; Ruhr University-Bochum’s Clara Saraceno; Leibniz University’s Michael Kues; Stanford University’s Jennifer Dionne; TU Dresden’s Andrés Fabián Lasagni; Columbia University’s Wei Min; Kobe University’s Osamu Matoba; Huazhong University of Science and Technology’s Dan Zhu; Baylor College of Medicine’s Irina Larina; University of California, Los Angeles’ Aydogan Ozcan; Massachusetts General Hospital, Harvard Medical School’s Maria Angela Franceschini; and Caltech’s Lihong Wang. Further plenary speakers will be announced soon.
In addition to the conferences and exhibitions, Photonics West also offers 41 training courses covering topics such as Introduction to VR/AR/MR and Smart Eyewear, Quantum Computing, and Practical Optical Systems. The wide-ranging educational program complements numerous professional development workshops, a comprehensive job fair, and many networking opportunities for technical professionals and exhibitors.
Included with full conference registration for Photonics West is access to the three-day SPIE AR | VR | MR conference which focuses on augmented, virtual, and mixed reality and the vital role that optics and photonics play in cross-reality (XR) hardware development. The event incorporates more than 40 invited industry talks, keynotes, and panels; a two-day exhibition; and, new in 2022, an XR-specific job fair. All of these components feature leading and upcoming consumer electronics companies, from Sony, Schott, and Microsoft to VividQ, Kura, and Lynx. There are also learning opportunities through courses, academic tracks, and a poster session.
"We are very excited to be hosting our in-person return to San Francisco, kicking off the calendar for the global photonics community’s year," notes SPIE Senior Director of Technical Programs and Photonics West Event Manager Marilyn Gorsuch. "Each year, Photonics West, as the first global photonics event of the year, shapes the future for academic, industry, and government communities. Photonics West 2022 promises to be an illuminating, engaging, and thought-provoking week with many networking and socializing opportunities planned to complement the strong technical program. We can’t wait to welcome our community back face-to-face, and once again show the value of live, in-person events.”
SPIE prioritizes the health and safety of its staff and global community. Following the guidance of government and public-health professionals, everyone who attends Photonics West will be required to submit proof of COVID-19 vaccination. SPIE will be carefully monitoring local, state, and national health regulations for any updates and changes. As of 8 November 2021, the US Government is lifting travel restrictions for vaccinated travelers from outside the US.
For more information and to register, please visit: https://spie.org/pw
SPIE is the international society for optics and photonics, an educational not-for-profit organization founded in 1955 to advance light-based science, engineering, and technology. The Society serves more than 258,000 constituents from 184 countries, offering conferences and their published proceedings, continuing education, books, journals, and the SPIE Digital Library. In 2020, SPIE provided over $5 million in community support including scholarships and awards, outreach and advocacy programs, travel grants, public policy, and educational resources. www.spie.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
'True Stories of Investing' - flatexDEGIRO drives financial education with high-quality documentation28.1.2022 10:48:00 CET | Press release
With "True Stories of Investing", flatexDEGIRO AG (WKN: FTG111, ISIN: DE000FTG1111, Ticker: FTK.GR), Europe's largest and fastest-growing retail online broker collaborates with award-winning documentary maker, New Amsterdam, and Discovery, to demystify investing. The documentary premieres on Discovery's channels across Europe starting this weekend and showcases important lessons every retail investor needs to know. In four episodes, renowned journalists, professors, behavioral scientists and investors challenge some of the biggest misconceptions about investing by examining historical events and the mechanisms at work. Frank Niehage, CEO of flatexDEGIRO: "It is our mission to retailise capital markets and empower private individuals to invest in a self-determined and sustainable way. As Europe's leading online broker, we feel responsible for making trading more simple, more informed, and more secure for our customers. With this innovative documentary, we take financial education one st
SoftBank Group Announces Management Transition28.1.2022 05:08:00 CET | Press release
SoftBank Group Corp. (“SoftBank”) today announced that the company and Marcelo Claure have mutually agreed to part ways after a successful nine-year partnership. In conjunction with Mr. Claure’s departure, Michel Combes has been appointed as CEO of SoftBank Group International (“SBGI”). In this position, he will oversee SoftBank Group International’s operating and investment portfolio*. Masayoshi Son, Representative Director, Corporate Officer, Chairman & CEO of SoftBank Group Corp., said, “Marcelo has made many contributions to SoftBank during his time here and we thank him for his dedication and wish him continued success in his future endeavors. I have great confidence in Michel Combes and the talented SoftBank team to continue with the great work we have underway at SBGI.” Mr. Claure said, “I will forever be grateful for my experience at SoftBank over the last nine years. I have had the opportunity to collaborate with some of the world’s great executives and entrepreneurs, and tack
JETRO Osaka (Japan External Trade Organization): Making an Innovation Movement From Osaka28.1.2022 03:00:00 CET | Press release
The Kansai region, which includes unique cities of Osaka, Kobe and Kyoto, is a massive market with a population of 24.65 million people and a GDP of approximately 100.05 trillion yen. It equals the metropolitan area centered on Tokyo as a site for business and plays the central role in the economy of Western Japan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220124005319/en/ Succeed Together in Japan and Beyond (Graphic: Business Wire) In this region, particularly on the Osaka Gulf Coast, there is a cluster of companies and research institutes related to the environmental and new energy industries. Also, throughout Osaka City, bio-related pharmaceutical companies and food manufacturers gather as well as the chemical and medical equipment companies. [Source] JETRO Investing in Japan “Osaka City” https://www.jetro.go.jp/en/invest/region/data/osaka-city.html O-BIC “Industry of Osaka” https://o-bic.net/e/attractive/ As the ho
KILL Seoul Semiconductor Proves the Effect of SunLike Lighting on Myopia Improvement28.1.2022 01:29:00 CET | Press release
KILL Seoul Semiconductor requests that their press release NewsItemId: 20220116005060, issued 17-Jan-2022 12:16 AM, “Seoul Semiconductor Proves the Effect of SunLike Lighting on Myopia Improvement” be killed. The release was issued in error by Seoul Semiconductor Co., Ltd. A replacement release will not be issued. Contact information Seoul Semiconductor Co., Ltd. Jinseop Jeong +82-70-4391-8555 email@example.com
GIANT Protocol Publishes Litepaper for Decentralized Internet Connectivity Economy27.1.2022 16:23:00 CET | Press release
GIANT Protocol, a leading-edge web3 protocol building a decentralized connectivity economy, today announced the release of its Litepaper, laying out the various components of GIANT Protocol’s ambitious proposal to decentralize and democratize access to the internet and financial services through a web3 telecommunications layer. GIANT plans to roll out the first iteration of its mainnet in the first half of 2022, so the publication of the Litepaper marks a critical step in ensuring GIANT Protocol’s commitment to being an open-source, public protocol built to support a globally connected world. GIANT Protocol made its debut in November 2021, announcing its intention to build a tokenized bandwidth platform that will allow anyone with a mobile phone to access the internet and earn rewards based on their connectivity. With a founding team well-established in the telecom sector, GIANT Protocol intends to leverage existing network providers, allowing it to rapidly scale its network. In Decemb
Lunaphore appoints Alice Feng as Chief Financial Officer27.1.2022 16:00:00 CET | Press release
Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced that Alice T. Feng will join the Lunaphore leadership team as Chief Financial Officer, effective January 31, 2022. Ms. Feng brings over two decades of finance and corporate development leadership experience as well as investment banking expertise, participating in over 30 merger and acquisition and financing transactions with aggregate transaction value of $45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220127005433/en/ Alice Feng (Photo: Lunaphore) “Alice brings deep expertise in corporate development and the capital markets and will play an instrumental role in our fundraising activities and leading the development of new partnerships as the company continues to expand globally,” said Ata Tuna Ciftlik, Ph.D., Chief Executive Officer of Lunaphore. “We are excited to work with Alice to ach
Croma-Pharma Completed the Decentralized Procedure for Its Botulinum Toxin to Treat Glabellar (frown) Lines27.1.2022 15:26:00 CET | Press release
Croma-Pharma (Croma), today announced that the decentralized procedure for its botulinum toxin to gain market authorization in Europe has been accomplished. This important step is the basis to complete Croma’s already comprehensive portfolio. Croma’s botulinum toxin submission in Europe is based on the data of 3 completed randomized, placebo-controlled phase III trials that enrolled a total of >1000 subjects in Europe and the US. National phases to grant the market authorization across Europe are following now. A game changer for Croma-Pharma and the aesthetic industry By adding its own botulinum toxin to the already broad portfolio Croma catapults itself to a new level within the aesthetic industry. Offering already a wide selection of HA fillers, PDO threads, PRP and scientific skincare products, the botulinum toxin was the missing piece to compete with world leaders in this sector. “We are pleased to announce that our toxin has now accomplished the decentralized procedure in Europe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom